Minimally Invasive Glaucoma Surgery Migs Devices Market Report
First published: 21 October 2024 | Last updated: 25 May 2026 | Report Code: minimally-invasive-glaucoma-surgery-migs-devices
Minimally Invasive Glaucoma Surgery Migs Devices Market — USD $2.8 Billion in 2023, Growing to USD 5.78null by 2033 at 7.3% CAGR
This report provides a comprehensive analysis of the Minimally Invasive Glaucoma Surgery (MIGS) Devices market from 2023 to 2033. It covers key trends, market size, regional analyses, and insights regarding technological advancements and product performance.
Key Takeaways
- Global market value increases from $2.80 Billion (2023) to $5.78 Billion (2033) with a 7.3% CAGR for 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Device categories include stents, shunts, and surgical instruments, serving Open Angle and Angle Closure Glaucoma.
- Leading firms covered include Allergan, Glaukos Corporation, Aquesys, and iScience Interventional.
- Market expansion is supported by advances in surgical tools, greater procedural awareness, and an aging demographic.
Minimally Invasive Glaucoma Surgery Migs Devices Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report assesses the market for minimally invasive glaucoma surgery devices across device types, applications, distribution channels, and end users. The market is forecast to grow from $2.80 Billion in 2023 to $5.78 Billion in 2033 at a 7.3% CAGR for 2023 to 2033. Growth is propelled by demographic shifts, rising glaucoma prevalence, and continuous improvements in surgical devices that enhance safety and recovery time. Segmentation covers device types such as stents, shunts, and surgical instruments; application areas including Open Angle and Angle Closure Glaucoma; and end users like hospitals and ophthalmology clinics. North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. Competitive coverage profiles established companies including Allergan, Glaukos Corporation, Aquesys, and iScience Interventional. Methodology combines primary interviews with industry specialists and secondary sources from corporate reports, followed by triangulation and expert validation to ensure robust findings.
Key Growth Drivers
- Rising prevalence of glaucoma associated with an aging population increases demand for less invasive surgical options.
- Technological improvement in device design and surgical instruments enhances safety and shortens recovery, encouraging adoption.
- Growing awareness of MIGS procedures among clinicians and patients expands treatment consideration beyond traditional surgeries.
- Distribution channel diversification, including direct sales and online retail, improves device accessibility across care settings.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.80 Billion |
| CAGR (2023-2033) | 7.3% |
| 2033 Market Size | $5.78 Billion |
| Top Companies | Allergan, Glaukos Corporation, Aquesys, iScience Interventional |
| Published Date | 21 October 2024 |
| Last Modified Date | 25 May 2026 |
Minimally Invasive Glaucoma Surgery Migs Devices Market Overview
Customize Minimally Invasive Glaucoma Surgery Migs Devices Market Report market research report
- ✔ Get in-depth analysis of Minimally Invasive Glaucoma Surgery Migs Devices market size, growth, and forecasts.
- ✔ Understand Minimally Invasive Glaucoma Surgery Migs Devices's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Minimally Invasive Glaucoma Surgery Migs Devices
What is the Market Size & CAGR of Minimally Invasive Glaucoma Surgery Migs Devices Market Report market in 2023?
Minimally Invasive Glaucoma Surgery Migs Devices Industry Analysis
Minimally Invasive Glaucoma Surgery Migs Devices Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Minimally Invasive Glaucoma Surgery Migs Devices Market Report Market Analysis Report by Region
Europe Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
Europe grows from $0.71 Billion in 2023 to $1.47 Billion in 2033. Growth in this region is driven by rising clinical awareness, investment in ophthalmic care, and ongoing technological refinements that make MIGS procedures more widely adopted.Asia Pacific Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
Asia Pacific grows from $0.56 Billion in 2023 to $1.16 Billion in 2033. The region's expansion is influenced by demographic shifts, increasing access to specialized eye care, and gradual adoption of minimally invasive interventions in urban centers.North America Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
North America is largest regional market, rising from $0.92 Billion in 2023 to $1.91 Billion in 2033. Regional uptake is linked to established clinical infrastructure, reimbursement frameworks favoring minimally invasive procedures, and strong adoption of new device technologies.South America Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
Latin America grows from $0.26 Billion in 2023 to $0.54 Billion in 2033. Market momentum reflects rising awareness of glaucoma treatments, incremental improvements in healthcare delivery, and expanding distribution channels for devices.Middle East & Africa Minimally Invasive Glaucoma Surgery Migs Devices Market Report:
Middle East and Africa grows from $0.34 Billion in 2023 to $0.7 Billion in 2033. Growth factors include expanding ophthalmic services, increased diagnostic capacity, and growing interest in less invasive surgical alternatives across tertiary care facilities.Tell us your focus area and get a customized research report.
Research Methodology
Minimally Invasive Glaucoma Surgery Migs Devices Market Analysis By Device Type
The MIGS devices market is primarily driven by the stents segment, which is estimated to maintain a significant market share. Stents are projected to grow from $1.77 billion in 2023 to $3.66 billion by 2033, catering to a large percentage of patients diagnosed with glaucoma. Shunts and surgical instruments are secondary devices but play an essential role in overall therapeutic strategies, with corresponding growth rates expected in line with stents.
Minimally Invasive Glaucoma Surgery Migs Devices Market Analysis By Application
The application segment is dominated by Open Angle Glaucoma, which is forecasted to capture the largest market share, growing from $1.77 billion in 2023 to $3.66 billion by 2033. Angle Closure Glaucoma and Secondary Glaucoma segments follow, reflecting significant growth trends due to awareness and diagnosis improvements.
Minimally Invasive Glaucoma Surgery Migs Devices Market Analysis By End User
The end-user analysis shows hospitals leading preference, expected to maintain a share of approx. 63.31% throughout the forecast period, as a primary platform for MIGS surgeries. Clinics and ambulatory surgery centers are also growing, responding to increased patient outflow and demand for outpatient procedures.
Minimally Invasive Glaucoma Surgery Migs Devices Market Analysis By Region
The distribution channel analysis indicates that direct sales remain predominant, contributing to approximately 63.31% of the market in 2023 and continuing until 2033. Distributors and online retail channels are increasingly adopted, enhancing market reach.
Minimally Invasive Glaucoma Surgery Migs Devices Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Minimally Invasive Glaucoma Surgery Migs Devices Industry
Allergan:
A prominent player in eye care, Allergan is known for its advanced MIGS technologies, significantly enhancing glaucoma treatment options.Glaukos Corporation:
A leader in the development of innovative MIGS procedures, Glaukos Corporation pioneered multiple stent solutions that have transformed the surgical approach to glaucoma treatment.Aquesys:
Aquesys specializes in developing minimally invasive stenting procedures and devices designed for glaucoma treatment, extensively focusing on patient recovery and procedural efficiency.iScience Interventional:
iScience is recognized for its advanced product portfolio, particularly its innovative techniques that help minimize complications while enhancing treatment outcomes.We're grateful to work with incredible clients.
FAQs
What is the market size in 2023?
The market size in 2023 is $2.80 Billion according to the report's base-year figure for Minimally Invasive Glaucoma Surgery MIGS devices.
How big will the market be in 2033?
The market is projected to reach $5.78 Billion by 2033 as stated in the forecast for the Minimally Invasive Glaucoma Surgery MIGS devices market.
What is CAGR for the forecast period?
The report specifies a compound annual growth rate (CAGR) of 7.3% for the 2023 to 2033 forecast period.
Is there a single fastest Growing region in the Minimally Invasive Glaucoma Surgery Migs Devices Market Report market?
No single fastest-growing region is stated for the Minimally Invasive Glaucoma Surgery Migs Devices Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which device types are profiled?
The study profiles device types including stents, shunts, and surgical instruments as primary categories in the Minimally Invasive Glaucoma Surgery market.
Who are the top companies featured?
Top companies included in the report are Allergan, Glaukos Corporation, Aquesys, and iScience Interventional.
What end users are analyzed?
End-user segments examined are hospitals, ophthalmology clinics, and ambulatory surgery centers as primary care settings for MIGS procedures.
How does distribution work in the market?
Distribution channels covered include direct sales, distributors, and online retail, highlighting multiple routes for device availability.
What are the primary market trends?
Key trends noted include device innovation, increasing clinician familiarity, and integration of advanced surgical tools to improve outcomes.
Why is the forecasted growth occurring?
Forecast growth is attributed to demographic change, technological progress in devices, and heightened awareness of minimally invasive treatment options.